Rita Kramer

1.5k total citations
18 papers, 628 citations indexed

About

Rita Kramer is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Rita Kramer has authored 18 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Rita Kramer's work include Cancer Risks and Factors (6 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (3 papers). Rita Kramer is often cited by papers focused on Cancer Risks and Factors (6 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (3 papers). Rita Kramer collaborates with scholars based in United States and Switzerland. Rita Kramer's co-authors include K. Sexton, Richard Elledge, Susan G. Hilsenbeck, Lois C. Friedman, Heidi L. Weiss, Jeffrey Crawford, John Hanfelt, Vered Stearns, Claudine Isaacs and Julia H. Rowland and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Rita Kramer

18 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rita Kramer United States	9	337	190	156	146	126	18	628
Mona El-Hashimy United States	11	347 1.0×	247 1.3×	53 0.3×	67 0.5×	46 0.4×	19	708
Manuel Vadillo-Buenfil Mexico	11	96 0.3×	129 0.7×	109 0.7×	264 1.8×	53 0.4×	13	578
Meng Huang China	15	183 0.5×	112 0.6×	127 0.8×	24 0.2×	53 0.4×	49	640
Joon Ho Song South Korea	10	133 0.4×	63 0.3×	223 1.4×	49 0.3×	36 0.3×	38	599
Gail S. Lebovic United States	13	226 0.7×	108 0.6×	145 0.9×	378 2.6×	46 0.4×	19	796
Ruthann I. Blough United States	13	120 0.4×	95 0.5×	187 1.2×	142 1.0×	21 0.2×	19	671
Yvonne Wallis United Kingdom	15	198 0.6×	146 0.8×	319 2.0×	48 0.3×	37 0.3×	26	1.1k
Charles Marcaillou France	8	107 0.3×	82 0.4×	93 0.6×	159 1.1×	126 1.0×	14	1.1k
J. W. Koper Netherlands	8	303 0.9×	56 0.3×	171 1.1×	409 2.8×	33 0.3×	10	1.0k
Nicole Sänger Germany	14	263 0.8×	87 0.5×	36 0.2×	32 0.2×	210 1.7×	56	717

Countries citing papers authored by Rita Kramer

Since Specialization

Citations

This map shows the geographic impact of Rita Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Kramer more than expected).

Fields of papers citing papers by Rita Kramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Kramer. The network helps show where Rita Kramer may publish in the future.

Co-authorship network of co-authors of Rita Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Kramer. A scholar is included among the top collaborators of Rita Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Kramer. Rita Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ford, Marvella E., Victoria J. Findlay, David P. Turner, et al.. (2020). BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivors. Advances in cancer research. 146. 83–102. 6 indexed citations

Cunningham, Joan E., et al.. (2018). Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship. Frontiers in Oncology. 8. 392–392. 2 indexed citations

Ford, Marvella E., Gayenell Magwood, Mathew J. Gregoski, et al.. (2016). Disparities in Obesity, Physical Activity Rates, and Breast Cancer Survival. Advances in cancer research. 133. 23–50. 12 indexed citations

Guo, Qi, et al.. (2015). Abstract A47: MicroRNA-510 as a predictive marker for response to platinum-based chemotherapy in triple negative breast cancer. Clinical Cancer Research. 21(4_Supplement). A47–A47. 1 indexed citations

Kramer, Rita, Jacek Bielawski, Emily Kistner‐Griffin, et al.. (2015). Neurotoxic 1‐deoxysphingolipids and paclitaxel‐induced peripheral neuropathy. The FASEB Journal. 29(11). 4461–4472. 61 indexed citations

Teller, Paige & Rita Kramer. (2010). Management of the asymptomatic BRCA mutation carrier. The Application of Clinical Genetics. 3. 121–121. 6 indexed citations

Wu, Meng-Fen, et al.. (2009). The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer. Breast Cancer Research and Treatment. 118(2). 369–375. 17 indexed citations

Sexton, K., et al.. (2007). The Rates of Chemotherapy-Induced Amenorrhea in Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide Followed by a Taxane. American Journal of Clinical Oncology. 30(2). 126–132. 121 indexed citations

Sexton, K., et al.. (2006). Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 107(4). 696–704. 185 indexed citations

10.

Sexton, K., et al.. (2006). The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause.. PubMed. 4(6). 295–8, 304. 10 indexed citations

11.

Kramer, Rita, et al.. (2005). Chemotherapy-induced amenorrhea is increased in patients treated with adjuvant doxorubicin and cyclophosphamide (AC) followed by a taxane (T). Journal of Clinical Oncology. 23(16_suppl). 651–651. 10 indexed citations

12.

Kramer, Rita & Powel H. Brown. (2004). Should Tamoxifen Be Used in Breast Cancer Prevention?. Drug Safety. 27(13). 979–989. 11 indexed citations

13.

Thompson, John S., Claire Pomeroy, Richard J. Kryscio, et al.. (2004). Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients. Biology of Blood and Marrow Transplantation. 10(12). 858–866. 6 indexed citations

14.

Kramer, Rita. (2004). 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on clinical research. Breast Cancer Research. 6(2). 84–7. 5 indexed citations

15.

Stearns, Vered, Claudine Isaacs, Julia H. Rowland, et al.. (2000). A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors. Annals of Oncology. 11(1). 17–22. 169 indexed citations

16.

Kramer, Rita & G. Drexler. (1981). Representative breast size of reference female. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 4 indexed citations

17.

Burstyn, Joan N. & Rita Kramer. (1979). Maria Montessori. History of Education Quarterly. 19(1). 143–143. 1 indexed citations

18.

Kramer, Rita. (1976). Maria Montessori : Leben und Werk einer großen Frau. Fischer Taschenbuch Verlag eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact